相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Therapeutic Potential of Green Synthesized Copper Nanoparticles Alone or Combined with Meglumine Antimoniate (Glucantime(R)) in Cutaneous Leishmaniasis
Aishah E. Albalawi et al.
NANOMATERIALS (2021)
Nitric-oxide releasing chitosan nanoparticles towards effective treatment of cutaneous leishmaniasis
Fernanda V. Cabral et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2021)
Nanoparticles: New agents toward treatment of leishmaniasis
Amir Nafari et al.
PARASITE EPIDEMIOLOGY AND CONTROL (2020)
Malaria-visceral leishmaniasis co-infection and associated factors among migrant laborers in West Armachiho district, North West Ethiopia: community based cross-sectional study
Yibeltal Aschale et al.
BMC INFECTIOUS DISEASES (2019)
Review of Leishmaniasis in the Middle East and North Africa
Ahmed Tabbabi
AFRICAN HEALTH SCIENCES (2019)
The impact of leishmaniasis on mental health and psychosocial well-being: A systematic review
Malini Pires et al.
PLOS ONE (2019)
Application of nanotechnology in treatment of leishmaniasis: A Review
Maryam Akbari et al.
ACTA TROPICA (2017)
Three Leishmania/L. species - L-infantum, L-major, L-tropica - as causative agents of mucosal leishmaniasis in Iran
Sadegh Shirian et al.
PATHOGENS AND GLOBAL HEALTH (2013)
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)
Viroj Wiwanitkit
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2012)
Leishmaniasis: complexity at the host-pathogen interface
Paul Kaye et al.
NATURE REVIEWS MICROBIOLOGY (2011)
Cross-protection against Leishmania donovani but not L-braziliensis caused by vaccination with L-major soluble promastigote exogenous antigens in BALB/c mice
Willy K. Tonui et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)